Connect with us

Health

Repeated Vaccination and S&P500 Inclusion Support the Generous Moderna (NASDAQ: MRNA) Valuation – Simply Wall St

While the Covid19 Pandemic disrupted whole economies worldwide, it sparked a race to develop an effective vaccine on a scale…

Published

on

Article feature image

While the Covid19 Pandemic disrupted whole economies worldwide, it sparked a race to develop an effective vaccine on a scale not seen ever before. Moderna, Inc. ( NASDAQ: MRNA ) is one of the companies that developed mRNA-1273, a 94.1% effective vaccine.

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending